Related Experiment Video
Updated: Jan 16, 2026

13:51
Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
10.3K
IMPDH and GTP Metabolism in Cancer: Mechanisms, Regulation, and Translational Scope
Aki Ogawa-Iio1, Koh Takeuchi2,3, Keita Shigemi2
1Division of Hematology and Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Cancer Science
|October 3, 2025
Summary
Guanosine triphosphate (GTP) fuels cancer growth, with IMPDH2 enzyme activity being a key factor. This review explores IMPDH2
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Guanosine triphosphate (GTP) is crucial for cancer cell proliferation.
- Inosine monophosphate dehydrogenase 2 (IMPDH2) regulates GTP levels and is a therapeutic target.
- Current IMPDH inhibitors have limitations, including side effects and unclear regulatory mechanisms.
Purpose of the Study:
- To systematically review IMPDH biology, focusing on its complex regulation in cancer.
- To highlight unresolved questions regarding IMPDH isozyme roles and regulatory escape mechanisms.
- To propose strategies for developing novel IMPDH-targeted cancer therapies.
Main Methods:
- Literature review of IMPDH biology and cancer relevance.
- Analysis of regulatory mechanisms, including GTP's paradoxical control of IMPDH.
- Identification of knowledge gaps and future research directions.
Main Results:
- IMPDH2 is a critical enzyme in GTP biosynthesis, elevated in tumors.
- IMPDH inhibitors show therapeutic potential but face challenges.
- Complex regulatory networks, including feedback loops, control IMPDH activity.
Conclusions:
- Understanding IMPDH regulation is key to optimizing cancer therapy.
- Further research into isozyme-specific functions and resistance mechanisms is needed.
- Targeting IMPDH offers a promising avenue for novel cancer treatments.
More Related Videos
Related Concept Videos
GTPases and their Regulation
9.7K
Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒ small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins,...
Large G-proteins,...
9.7K
GTPases and their Regulation
2.9K
2.9K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Small GTPases - Ras and Rho
5.2K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
5.2K
The Ras Gene
7.0K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.0K
Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K

